• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Robyn Barberry
          • Hanael Bianchi
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Books/CDs/Prayer Cards
        • CR Media platforms
        • Electronic Edition
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
        • Magazine Subscriptions
        • Archdiocesan Directory
  • CR Radio
        • CR Radio
        • Protagonistas de Fe
        • In God’s Image
  • News Tips
  • Subscribe
A box of the RU-486 drug, known generically as mifepristone and by its brand name Mifeprex, is seen in an undated handout photo. The U.S. FDA has approved distributing of the abortion pill through retail pharmacies, a move that could transform the US abortion industry and poses new challenges to the church's pro-life ministry. (OSV News photo/courtesy Danco Laboratories)

New abortion pill rules challenge Catholics to reimagine effective pro-life outreach

January 15, 2023
By Kimberly Heatherington
OSV News
Filed Under: Feature, News, Respect Life, World News

WASHINGTON (OSV News) — Just six months after the U.S. Supreme Court’s landmark Dobbs v. Jackson Women’s Health Organization decision that abortion is not a constitutional right, America’s pro-life advocates and health care providers are preparing for another consequential shift following the U.S. Food and Drug Administration’s finalization of a rule change that expands availability of the abortion pill mifepristone.

In a Jan. 6 statement, Bishop Michael F. Burbidge of Arlington, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities, denounced the move.

“The Catholic Church is consistent in its teaching on upholding the dignity of all life, and that must include care for both women and their children,” Burbidge said. “We decry the continuing push for the destruction of innocent human lives and the loosening of vital safety standards for vulnerable women.”

Bishop Michael F. Burbidge of Arlington, Va., incoming chairman of the U.S. bishops’ Committee on Pro-Life Activities, speaks during a Nov. 16, 2022, session of the fall general assembly of the bishops’ conference in Baltimore. (CNS photo/Bob Roller)

The FDA announced early January that under its modified Mifepristone REMS Program, patients will be able to acquire Mifeprex — and its approved generic — at retail pharmacies. According to the FDA website, “a Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.”

When used in combination with misoprostol, mifepristone — introduced 20 years ago — induces a “medication abortion” up to 10 weeks into a pregnancy. The same pills used for abortions are also prescribed to women who experience early pregnancy miscarriage.

The Guttmacher Institute reported in December 2022 that their census of all known abortion providers found “medication abortion accounted for 53 percent of all facility-based abortions in the United States in 2020.”

The FDA’s January announcement, however, portends to accelerate the transition of first trimester abortion — 90 percent of all abortions in the U.S. — from a surgical procedure to a medication experience. It builds on a December 2021 FDA rule change that allows telemedicine consultations with mail-order pharmacy fulfillment, reversing a prior requirement for in-person consultation.

Both Walgreens and CVS plan to offer mifepristone in states where it is legal. While many states still restrict abortion pill use, state policies may change in the aftermath of the FDA’s latest rule modification.

The FDA’s rule changes, however, is forcing pro-life advocates to rethink effective, lifesaving strategies, as more women seeking an abortion no longer require visiting a physical clinic.

Molly Sheahan, associate director of Life & Family Advocacy at the California Catholic Conference, noted the digital dimension of securing abortion pills requires the pro-life movement to understand where it needs to be.

“The frontier on the issue of abortion isn’t necessarily the abortion clinic — it’s the mobile phone,” said. “Women are seeking abortion by searching online … they’re able to order abortion pills through the mail. That’s been available for a while — it’s just become more readily accessible now.”

In response, the California Catholic Conference utilizes social media and digital ads to reach women in the state, where abortion appointments have markedly increased post-Dobbs.

“It just creates additional concern for women when they’re not able to be seen by a physician to screen them for contraindications,” said Sheahan. “We’re putting vulnerable people at greater risk when we’re not serving them in a physician’s office.”

Leah Jacobson, CEO and founder of Guiding Star Project, a nationwide network of pro-life health centers, said the normalization of the Plan B emergency contraceptive “has been so normalized that a woman doesn’t even think twice.”

“Many college-age women have used Plan B on several occasions — and the abortion pill, to them, is just a next back-up step in case Plan B failed,” she said.

Guiding Star has focused on fostering an early interaction with patients — as young as age 9 — about healthy life choices. In the event their patients experience an unplanned pregnancy, they can turn to Guiding Star for life-affirming care, support and resources.

A statement released by the Catholic Medical Association’s former president Lester Ruppersberger, D.O., and Marie T. Hilliard, Ph.D., senior fellow at the National Catholic Bioethics Center, backed up that concern, saying the FDA’s changes put at risk women’s “true informed consent.

“Furthermore, no onsite or in-person physical assessment to even document the weeks of gestation or the location of the fetus is required,” they stated. Without follow-up physical examination to assess a potentially incomplete abortion, CMA notes increased “risks of continued bleeding, retained products of conception necessitating surgical removal, or infections, which can lead to infertility and in extreme cases even death.”

The CMA further cautioned that “removing the requirement for in-person dispensing facilitates the potential for concealing rape of a minor.” Such concerns also extend to human trafficking victims.

Katherine Talalas, assistant director for Pro-Life Communications for the U.S. Conference of Catholic Bishops, told OSV News it is critical for Catholics to inform, advocate at state and federal levels, and pastorally assist.

The majority of abortion-minded women fall below the poverty line, are unmarried, and lack social or financial support, Talalas explained. She said the USCCB’s Walking with Moms in Need initiative — a parish-based process that assists vulnerable pregnant women — seeks to provide a safety net for all, “whether you are in a red state, a blue state, a state that already has a lot of regulations on abortion or none.”

Abandoning women to the trauma of chemical abortion, which always involves a delivery of some kind, is cruel, Talalas stressed.

“Abortion doesn’t make a baby disappear,” she said. “It just means that the baby’s life is ended.”


Kimberly Heatherington is an OSV News correspondent who writes from Virginia.

Read More Respect Life

Bishops praise Virginia Legislature for halting assisted suicide bill

‘Unborn children are dying’: Pro-life leaders challenge ICE detention of pregnant women

Bishops, pro-life leaders slam Notre Dame pro-abortion appointment as ‘slap in face,’ ‘betrayal’

Ave Maria University battles measles outbreak

Trump Justice Department has made protests at places of worship a FACE Act priority

Bishop Rhoades calls on Notre Dame to reverse new director’s appointment over abortion advocacy

Copyright © 2023 OSV News

Print Print

Primary Sidebar

Kimberly Heatherington

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • ‘Unborn children are dying’: Pro-life leaders challenge ICE detention of pregnant women

  • A quick guide to fasting in Lent

  • Deacon Jack Ames, Project Rachel volunteer and educator, dies at 74

  • ‘Remember you are dust’: Why people fill the pew on Ash Wednesday

  • Archdiocese of Baltimore couples share stories of love that lasts a lifetime 

| Latest Local News |

Baltimore chapter of Young Catholic Professionals celebrates successful first year

Mount St. Joseph’s BJ Ransom selected as BCL Player of Year; league unveils new academic honors

Radio Interview: Archbishop Lori’s pastoral letter: ‘In Charity and Truth’

St. Carlo Acutis Camping Retreat builds faith in the great outdoors 

Notre Dame Prep develops new commons area

| Latest World News |

Holy See will not join Trump’s ‘Board of Peace’ for Gaza, Cardinal Parolin says

Pope Leo XIV calls for ‘countercultural’ repentance on first Ash Wednesday of his pontificate

Bishops praise Virginia Legislature for halting assisted suicide bill

Diocese of Camden reaches ‘long overdue’ $180 million abuse settlement

Death is close; Jesus and his love are closer, say clergy in Ukraine war zone

| Catholic Review Radio |

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • Holy See will not join Trump’s ‘Board of Peace’ for Gaza, Cardinal Parolin says
  • Pope Leo XIV calls for ‘countercultural’ repentance on first Ash Wednesday of his pontificate
  • Bishops praise Virginia Legislature for halting assisted suicide bill
  • Diocese of Camden reaches ‘long overdue’ $180 million abuse settlement
  • Question Corner: Why doesn’t the Church require more demanding fasting for Lent?
  • Death is close; Jesus and his love are closer, say clergy in Ukraine war zone
  • Olympic ski jumping silver, bronze medals lay on altar as young athlete’s faith goes viral
  • Remembering Angelo Gugel
  • Movie Review: ‘The Strangers – Chapter 3’

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2026 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED